
Knowles just turned in its Q3 2026 scorecard and the stock reaction is firmly risk off. The shares finished Friday down 3.5% at US$32.20, even as the business posted US$184 million in sales and US$0.38 in earnings per share at the high end of guidance.
The real story sits in profitability. Net income from ongoing operations reached US$21.2 million, and the trailing net margin now runs at 11.5%. That is a sharp reset in earnings power for an electronic components supplier, while the market trades the ticker as if the latest quarter were a letdown.
Love the reset in Knowles profitability but concerned the market still treats the stock as a letdown story after this quarter? Compare it with a curated set of peers in our list of solid balance sheet and fundamentals stocks (25 results)
Knowles says 2027 will beat its own growth targets. Ask Charlie which Knowles growth bets matter most for 2027.
The upbeat pitch around Knowles hinges on a mix shift toward custom hardware paying off in meaningfully higher profitability. That claim is explicit.
"The main requirement is for Knowles to sustain its shift toward high-value, custom-engineered components and specialty film capacity while keeping EBITDA margins on track toward the higher levels targeted by management."
Q3 gives you concrete progress against that bar. Precision Devices revenue of US$117 million grew faster than the group and carried a 41.6% gross margin. Companywide, trailing net margin now runs at 11.5%, and management reaffirmed a path to higher EBITDA margins, with Q4 guidance pointing to 23% to 25% adjusted EBIT.
Not everyone reads the same price the same way. → See the higher figure this Narrative lands on, and how it gets there.
The bearish view argues that Knowles might again fail to turn healthy demand into lasting expansion.
"Although Knowles is currently pointing to faster growth in medtech, defense, and industrial demand, the company’s history of a 5.2% annual revenue decline over the last five years suggests prior end market strength has not reliably converted into sustainable top-line expansion."
Q3 does not fully settle that concern. Precision Devices delivered US$117 million with strong book to bill, and group revenue landed at the top of guidance. Yet the specialty film capacity bet still sits largely on one US$75 million energy order, and management flagged capacity constraints and timing risks. The growth problem is not solved, just deferred.
Knowles shows that earnings progress and share moves can diverge in the short term. The real opportunity is focusing on stocks that could be undervalued before that gap narrows.
That is three of the list. See the full list of 27 companies trading below our fair value estimates →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com